PDCD1 and neoplasm: Oral supplementation of the bacteria with A. muciniphila to antibiotic-treated mice after receiving FMT from non-responders restored the effectiveness of PD-1 blockade in an interleukin-12-dependent manner, enhancing the recruitment of CCR9+CXCR3+CD4+T lymphocytes to the tumor beds (12, 16).